J 2023

Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19

MYSKA, Vojtech, Samuel GENZOR, Anzhelika MEZINA, Radim BURGET, Jan MIZERA et. al.

Basic information

Original name

Artificial-Intelligence-Driven Algorithms for Predicting Response to Corticosteroid Treatment in Patients with Post-Acute COVID-19

Authors

MYSKA, Vojtech (203 Czech Republic, guarantor), Samuel GENZOR (203 Czech Republic), Anzhelika MEZINA (203 Czech Republic), Radim BURGET (203 Czech Republic), Jan MIZERA (203 Czech Republic), Michal STYBNAR (203 Czech Republic), Martin KOLARIK (203 Czech Republic), Milan SOVA (203 Czech Republic, belonging to the institution) and Malay Kishore DUTTA

Edition

Diagnostics, Basel, MDPI, 2023, 2075-4418

Other information

Language

English

Type of outcome

Článek v odborném periodiku

Field of Study

30203 Respiratory systems

Country of publisher

Switzerland

Confidentiality degree

není předmětem státního či obchodního tajemství

References:

Impact factor

Impact factor: 3.600 in 2022

RIV identification code

RIV/00216224:14110/23:00133302

Organization unit

Faculty of Medicine

UT WoS

000998282700001

Keywords in English

personalised medication recommendation algorithms; artificial intelligence; post-COVID syndrome; prediction model; respiratory system; corticosteroids; eHealth

Tags

Tags

International impact, Reviewed
Změněno: 5/4/2024 09:21, Mgr. Tereza Miškechová

Abstract

V originále

Pulmonary fibrosis is one of the most severe long-term consequences of COVID-19. Corticosteroid treatment increases the chances of recovery; unfortunately, it can also have side effects. Therefore, we aimed to develop prediction models for a personalized selection of patients benefiting from corticotherapy. The experiment utilized various algorithms, including Logistic Regression, k-NN, Decision Tree, XGBoost, Random Forest, SVM, MLP, AdaBoost, and LGBM. In addition easily human-interpretable model is presented. All algorithms were trained on a dataset consisting of a total of 281 patients. Every patient conducted an examination at the start and three months after the post-COVID treatment. The examination comprised a physical examination, blood tests, functional lung tests, and an assessment of health state based on X-ray and HRCT. The Decision tree algorithm achieved balanced accuracy (BA) of 73.52%, ROC-AUC of 74.69%, and 71.70% F1 score. Other algorithms achieving high accuracy included Random Forest (BA 70.00%, ROC-AUC 70.62%, 67.92% F1 score) and AdaBoost (BA 70.37%, ROC-AUC 63.58%, 70.18% F1 score). The experiments prove that information obtained during the initiation of the post-COVID-19 treatment can be used to predict whether the patient will benefit from corticotherapy. The presented predictive models can be used by clinicians to make personalized treatment decisions.